Vesalius BioCapital and Swisscanto Invest have co-led a €19m series-B funding round for OncoDNA, a Belgium-based company that develops tests for cancer diagnosis.
Danish venture capital firm exits the business after having invested in it in 2016
Restructuring agreement will reduce the company's current debt, amounting to €575m, to €242m
Former partner at IBM Ventures Christoph Auer-Welsbach joins Kaizo as a co-founder
GP has taken a significant minority stake in the Germany-based data privacy software provider